The influence of atypical neuroleptics on the immune system of patients with schizophrenia

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk

Volumn , Issue 3, 2007, Pages 14-19

  Kolyaskina, G I ^a   Sekirina, T P ^a   Androsova, L V ^a   Kushner, S G ^a   Vasilyeva, Ye F ^a   Burbayeva, O A ^a   Morozova, M A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248359537     PISSN: 08696047     EISSN: 24143545     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ganguli R., Brar J. S., Chengappa K. N. et al. Autoimmunity in schizophrenia: A review of recent findings. Ann. Med. 1993: 25: 489-496.
2. Ganguli R., Brar J. S., Rabin B. S. Immune abnormalities in schizophrenia: Evidence for the autoimmune hypothesis. Harv. Rev. Psychiatry 1994; 2: 70-83.
3. Kirch D. Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal. Schizophr. Bull. 1993; 19 (2): 355-364.
4. Kolyaskina G. I., Sekirina T. P., Andnsova L. V. et al. Immunological studies in schizophrenia. Ann. Psychiatry 1996; 6: 105-122.
5. Muller N., Gruber R., Ackenheil M., Schwarz M. J. The immune system and schizophrenia. An integrative view. Ann. N. Y. Acad. Sci. 2000; 917: 456-467.
6. Noy S., Achiron A., Laor N. Schizophrenia and autoimmunity - a possible etiological mechanism? Neuropsychobiology 1994; 30: 157-159.
7. Vertanian M. E., Kplyaskina G. I. A psychiatrist's view of neuroimmunomodulation. The neuroimmune interaction and mechanisms. Ann. N. Y. Acad. Sci. 1980; 496: 660-668.
8. Yolken R. H., Torrey E.. Viruses, schizophrenia, and bipolar disorder. Clin. Microbiol. Rev. 1995; 8: 131-145.
9. Wang X.-F., Wang D., Zhu W. et al. Studies characterizing 60kDa autoantibodies in subjects with schizophrenia. Biol. Psychiatry 2003; 53: 361-375.
10. Rapaport M. H., Muller N. Immunological states associated with schizophrenia. Psychoneuroimmunology 2001; 2: 372-382.
11. Delrahim K., Rapaport M. H. An abbreviated review of immune abnormalities in schizophrenia. CNS Spectrums 2001; 6: 392-397.
12. Kolyaskina G. I., Sekirina T. P., Zozulya A. A. et al. Some aspects of immunologic studies in schizophrenia. In: Kurstak E., Lipowski Z. J., Morozov P. V., eds. Viruses, immunity, and mental disorders. New York; London: Plenum Medical Book Company; 1987. 285-294.
13. Rapaport M. H., McAllister C. G., Kirch D. G., Pickar D. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness. Biol. Psychiatry 1991; 29: 715-717.
14. Zarrabi M. H., Zucker S., Miller F. et al. Immunologic and coagulation disorders in chlorpromzine-treated patients. Ann. Intern. Med. 1979; 91: 194-199.
15. Kay S. R., Fiszbein A., Opler L. A. Negative symptom rating scale: limitations in psychometric and research methodology. Psychiatry Res. 1986; 19: 169-170.
16. Kay S. R., Fiszbein A., Opler L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987; 13: 261-276.
17. Russian source
18. Russian source
19. Russian source
20. Russian source
21. Russian source